Synthes forced to sell bone void filler subsidiary after guilty Fed charge
This article was originally published in Clinica
Executive Summary
Swiss orthopaedics firm Synthes is to sell one of its US units, Norian, by May 2011 after the latter was found guilty of illegally promoting the off-label use of its bone filler products.